Ugur Sahin, chief executive officer of BioNTech SE, reported an open-market sale of 72,000 shares of $BNTX on October 5, 2026. The trade cleared at an average price of $97.2312 per share, for a total of $7,000,646.40. Sahin filed the Form 4 with the SEC on October 6, one day after the transaction. The filing listed reported ownership of 108,209 shares after the sale.
The October 5 sale was the largest in a sequence of open-market sales Sahin disclosed across late September and early October. On October 6, he reported a separate sale of 21,000 shares at $96.8093 per share, valued at $2,032,995.30, leaving reported ownership of 87,209 shares. Earlier filings in the sequence included a 32,000-share sale on September 30 at $98.1203, a 34,000-share sale on September 29 at $98.2591, a 39,000-share sale on September 24 at $98.9913, and a 30,000-share sale on September 23 at $99.4027. The September 18, September 17, September 16, and September 15 filings reported open-market sales of 30,000, 34,000, 15,000, and 34,000 shares, respectively.
Across the ten open-market sales from September 15 through October 6, Sahin reported transactions totaling 341,000 shares and approximately $33.3 million, based on the Form 4 values. The filings listed reported ownership of 568,209 shares after the September 15 sale and 87,209 shares after the October 6 sale.
On October 5, $BNTX traded between $95.20 and $98.785 and closed at $97.64. The October 5 sale price of $97.2312 fell within that intraday range.
The most recent BioNTech Form 4 before that stretch came from chief operating officer Sierk Poetting, who sold 50,000 shares on April 22 at $110.5592 per share, a transaction valued at $5,527,960 and filed on April 23. The Form 4 records for the September 15 to October 6 window listed only Sahin among BioNTech insiders.
Congressional STOCK Act records show the most recent BioNTech-related disclosure came from Representative Valerie Hoyle, who reported a sale on August 7, 2025, and disclosed it on September 12, 2025, a delay of 36 days. That disclosure carried a midpoint value of $1,001. Congressional dollar figures reflect midpoint estimates of the disclosed bracket ranges rather than exact transaction values.